Sign Up Today and Learn More About Sanoculis Stock
Invest in or calculate the value of your shares in Sanoculis or other pre-IPO companies through EquityZen's platform.
Sanoculis Stock (SANC)
Sanoculis is a medical device start-up company that develops an innovative surgical procedure for the treatment of the Glaucoma.
About Sanoculis Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
Sanoculis Press Mentions
Stay in the know about the latest news on Sanoculis
Regulatory actions for April 17, 2025
bioworld • Apr 18, 2025
Sanoculis Receives CE Mark for MINT® Product for the Treatment of Glaucoma
prnewswire • Apr 17, 2025
Device and method for creating a channel in soft tissue
patents • Apr 15, 2024
Apparatus for tissue removal
patents • Apr 15, 2024
Devices and methods for removing soft tissue and creating a channel in the soft …
patents • Apr 15, 2024
Sanoculis Management
Leadership team at Sanoculis
Co-Founder and CEO
Nir Israeli
Medical Director and Co-Founder
Yoseph Glovinsky
Join now and verify your accreditation status to gain access to:
- Sanoculis Current Valuation
- Sanoculis Stock Price
- Sanoculis Management
- Available deals in Sanoculis and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Sanoculis Cap Table and Funding History by Share Class and Liquidity Preferences
- Sanoculis Revenue and Financials
- Sanoculis Highlights
- Sanoculis Business Model
- Sanoculis Risk Factors
- Sanoculis Research Report from SACRA Research
Trading Sanoculis Stock
How to invest in Sanoculis stock?
Accredited investors can buy pre-IPO stock in companies like Sanoculis through EquityZen funds. These investments are made available by existing Sanoculis shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sanoculis stock?
Shareholders can sell their Sanoculis stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
